Navigation Links
Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results
Date:12/10/2007

re.

2007 Fourth Fiscal Quarter Financial Results

For the fourth fiscal quarter of 2007, Tutogen reported a 41% increase in revenues to $15.2 million compared to $10.8 million in the fourth quarter of fiscal year 2006. Overall U.S. product sales increased 38% for the fourth fiscal quarter of 2007 compared to the same period in 2006, and international sales increased 47% on the same comparative basis. When comparing the fourth fiscal quarter of 2007 with that of 2006, dental product sales increased 34%; spine products sales increased 23%; and surgical specialties product sales increased 69%. The fourth quarter gross margin was 50% due to unusually high write-offs of inventory ($538,000 or 4% impact on the gross margin), seasonality in dental sales for the fourth quarter, unfavorable product mix/yields and backorders of certain high margin tissue products. The gross margin is expected to be in the 53-55% range for the first quarter of fiscal year 2008 and to approach the 57-59% range in subsequent quarters due to continued growth in high margin dental sales, price increases over various products lines during the first and second quarters of 2008, the filling of backorders of high margin tissue products particularly with the addition of multiple new tissue sourcing deals and additional production efficiencies with higher volumes and improved product yields. The expenses in the fourth quarter included unusual general and administrative charges of $427,000 for Sarbanes Oxley compliance matters and $290,000 in connection with the relocation of Company executives and $334,000 in tax expense related to the aforementioned change in the German corporate tax rate. As a result, the Company reported a net loss of $440,000, or $0.02 loss per fully diluted share, in the fourth fiscal quarter of 2007 compared to net income of $599,000, or $0.04 per fully diluted share, in the comparable quarter last year. Excluding the gross margin items and general and administrative
'/>"/>

SOURCE Tutogen Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
3. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
4. Tutogen Medical, Inc. to Report Fourth Quarter and Fiscal Year 2007 Financial Results
5. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
6. QMed, Inc. Reports July Medicare SNP Enrollments
7. Phlo Affiliate Reports Expanded Coverage to Oregon Border
8. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Carrington Reports Second Quarter 2007 Results
11. Avitar Reports Third Quarter Financial Results for Fiscal 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... July 14, 2014 Cloud Pharmaceuticals, Inc., ... and development, announced today the expansion of its ... been granted supercomputing time at Argonne National Laboratory ... Through a discretionary allocation of 1 ... (ALCF), researchers at Cloud Pharmaceuticals will use Mira, ...
(Date:7/14/2014)... Throughout this past June 100s of ... space, representing 38 countries globally, registered for Xtalks ... Participation in Clinical Trials. Attract. Engage. Retain.” , ... R&D expert, Ken Getz, of Tufts CSDD, who ... through Patient Centricity. , Throughout this complimentary six-part ...
(Date:7/14/2014)... 2014 Minerva Neurosciences (NASDAQ: NERV ... to treat neuropsychiatric diseases and disorders, today announced that ... president of finance and chief accounting officer, effective June ... executive with more than 20 years of experience in ... companies. His background includes the management of compliance and ...
(Date:7/14/2014)... San Mateo, CA (PRWEB) July 14, 2014 ... groundbreaking CONNECT patient registry platform, announced that ... Becker muscular dystrophies; the Phelan-McDermid Syndrome International ... primary Nephrotic Syndrome—have been awarded contracts by ... part of the creation of a new ...
Breaking Biology Technology:Cloud Pharmaceuticals Granted 1M Hours of Supercomputer Time to Target Orphan Diseases Including Malaria 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 3Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 4Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 5Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 2PatientCrossroads Fuels Development of New National Clinical Research Network 2PatientCrossroads Fuels Development of New National Clinical Research Network 3
... ... Hermes Biosciences and partnership with sanofi-aventis , ... Cambridge, MA (PRWEB) April 7, 2010 -- Merrimack Pharmaceuticals, Inc., ... for cancer and inflammation, today announced that William Sullivan has been promoted to Vice ...
... have found a way to turn a precision measurement device ... researchers adapted a device known as an optical frequency comb ... data operations that will be vital for future quantum computers. ... Review Letters and is described in a Viewpoint article ...
... ... to build and sell "Flexible Fuel" cars, as would be required by ... the impact of the stricter fuel efficiency standards announced today by President ... President,s announcement, advocates of energy independence challenged the President to show his ...
Cached Biology Technology:Merrimack Pharmaceuticals Promotes William Sullivan to Vice President of Finance 2Challenge President to Adopt Energy Measure with Double the Impact of Improved Auto Fuel Efficiency Standards at Fraction of the Cost 2
(Date:7/14/2014)... news release is available in German . ... segmental patterns that manifest themselves during development. One classical ... precursors of the backbone, a process that has been ... embryo the "segmentation clock". Until now, this patterning ... time scale of genetic oscillations that periodically trigger new ...
(Date:7/14/2014)... July 14, 2014 MedNet Solutions ... in clinical study management systems, is pleased to ... equity firm focused on software-as-a-service (SaaS) and Internet-based ... MedNet Solutions.  This funding, representing the first major ... instrumental in supporting the ongoing growth and development ...
(Date:7/14/2014)... 14, 2014 Research and Markets has ... 2014: Applications for Microfluidic Technologies" report to their offering. ... testing based on microfluidic technology is expected to grow sharply, ... CAGR 2014 - 2019 of 23%. Major diagnostics companies (Alere, ... etc.) have realized the potential of rapid molecular diagnostic testing. ...
Breaking Biology News(10 mins):Timing is not only ticking 2Timing is not only ticking 3Arrowroot Capital Invests $4 Million In MedNet Solutions 2Arrowroot Capital Invests $4 Million In MedNet Solutions 3Applications for Microfluidic Technologies in Point of Care Testing: 2014 Report 2Applications for Microfluidic Technologies in Point of Care Testing: 2014 Report 3
... in decks, utility poles and fences will likely leach ... groundwater, according to two research papers published online Wednesday. ... of Florida and Florida International University examined arsenic leaching ... real deck as well as from simulated landfills. , ...
... using MRI to detect magnetic probes of tiny iron ... time has successfully tracked immune-stimulating cells implanted into cancer ... the eight patients, MRI revealed that the implanted cells ... for treatment," says Jeff Bulte, Ph.D., an associate professor ...
... chicken when she crossed the road is less important that what ... , Organic arsenic is fed to poultry to prevent bacterial infections ... up by the tissue and the majority of it is excreted ... urine from under poultry houses -- is rich in nitrogen and ...
Cached Biology News:Researchers: Treated wood poses long-term threat 2Researchers: Treated wood poses long-term threat 3Magnetic probe successfully tracks implanted cells in cancer patients 2Magnetic probe successfully tracks implanted cells in cancer patients 3Geoscientists follow arsenic from chicken feed to streambeds 2
Rabbit polyclonal to Tryptophanyl tRNA synthetase ( Abpromise for all tested applications). Antigen: Recombinant full length protein (Human): Tryptophanyl tRNA synthetase Entrez Gene ID: 745...
WTAP Antibody...
Anti-Dardarin Immunogen: Synthetic peptide from rat LRRK2. Available Date: 38814...
... Rabbit polyclonal to MSY2/YBOX2 ( Abpromise ... Antigen: Synthetic peptide ... the C-terminus of Human MSY2/YBOX2. ... proprietary) (Peptide available ...
Biology Products: